| [1] |
Bray F, Ferlay J, Soerjomataram I, et al.Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J].CA Cancer J Clin, 2018, 68(6):394-424
|
| [2] |
Safi AF, Grochau K, Drebber U, et al.A novel histopathological scoring system for patients with oral squamous cell carcinoma[J].Clin Oral Investig, 2019, 23(10):3759-3765
|
| [3] |
Pobbati AV, Hong W.Emerging roles of TEAD transcription factors and its coactivators in cancers[J].Cancer Biol Ther, 2013, 14(5):390-398
|
| [4] |
Yagi R, Kohn MJ, Karavanova I, et al.Transcription factor TEAD4 specifies the trophectoderm lineage at the beginning of mammalian development[J].Development, 2007, 134(21):3827-3836
|
| [5] |
Knight JF, Shepherd CJ, Rizzo S, et al.TEAD1 and c-Cbl are novel prostate basal cell markers that correlate with poor clinical outcome in prostate cancer[J].Br J Cancer, 2008, 99(11):1849-1858
|
| [6] |
Liu Y, Wang G, Yang Y, et al.Increased TEAD4 expression and nuclear localization in colorectal cancer promote epithelial-mesenchymal transition and metastasis in a YAP-independent manner[J].Oncogene, 2016, 35(21):2789-2800
|
| [7] |
Kang W, Huang T, Zhou Y, et al.miR-375 is involved in Hippo pathway by targeting YAP1/TEAD4-CTGF axis in gastric carcinogenesis[J].Cell Death Dis, 2018, 9(2):92-
|
| [8] |
Zhou Y, Huang T, Zhang J, et al.TEAD1/4 exerts oncogenic role and is negatively regulated by miR-4269 in gastric tumorigenesis[J].Oncogene, 2017, 36(47):6518-6530
|
| [9] |
Li Z, Wang Y, Qiu J, et al.The polycomb group protein EZH2 is a novel therapeutic target in tongue cancer[J].Oncotarget, 2013, 4(12):2532-2549
|
| [10] |
Wu Y, Diao P, Li Z, et al.Overexpression of WD repeat domain 5 associates with aggressive clinicopathological features and unfavorable prognosis in head neck squamous cell carcinoma[J].J Oral Pathol Med, 2018, 47(5):502-510
|
| [11] |
Li J, Li Z, Wu Y, et al.The Hippo effector TAZ promotes cancer stemness by transcriptional activation of SOX2 in head neck squamous cell carcinoma[J].Cell Death Dis, 2019, 10(8):603-
|
| [12] |
Zanconato F, Forcato M, Battilana G, et al.Genome-wide association between YAP/TAZ/TEAD and?AP-1 at enhancers drives oncogenic growth[J].Nat Cell Biol, 2015, 17(9):1218-1227
|
| [13] |
Plouffe SW, Meng Z, Lin KC, et al.Characterization of Hippo Pathway Components by Gene Inactivation[J].Mol Cell, 2016, 64(5):993-1008
|
| [14] |
Stein C, Bardet AF, Roma G, et al.YAP1 Exerts Its Transcriptional Control via TEAD-Mediated Activation of Enhancers[J].PLoS Genet, 2015, 11(8):e1005465-
|
| [15] |
Lehmann W, Mossmann D, Kleemann J, et al.ZEB1 turns into a transcriptional activator by interacting with YAP1 in aggressive cancer types[J].Nat Commun, 2016, 7:10498-
|
| [16] |
Zhang Q, Fan H, Zou Q, et al.TEAD4 exerts pro-metastatic effects and is negatively regulated by miR6839-3p in lung adenocarcinoma progression[J].J Cell Mol Med, 2018, 22(7):3560-3571
|
| [17] |
Tang JY, Yu CY, Bao YJ, et al.TEAD4 promotes colorectal tumorigenesis via transcriptionally targeting YAP1[J].Cell Cycle, 2018, 17(1):102-109
|
| [18] |
Suzuki M, Kondo A, Ogino I, et al.Overexpression of TEAD4 in atypical teratoid/rhabdoid tumor: New insight to the pathophysiology of an aggressive brain tumor[J].Pediatr Blood Cancer, 2017, 64(7):e26398-
|
| [19] |
Nowee ME, Snijders AM, Rockx DA, et al.DNA profiling of primary serous ovarian and fallopian tube carcinomas with array comparative genomic hybridization and multiplex ligation-dependent probe amplification[J].J Pathol, 2007, 213(1):46-55
|
| [20] |
Takeuchi S, Kasamatsu A, Yamatoji M, et al.TEAD4-YAP interaction regulates tumoral growth by controlling cell-cycle arrest at the G1 phase[J].Biochem Biophys Res Commun, 2017, 486(2):385-390
|
